Keywords: Cell Therapeutics, Pixuvri, Non-Hodgkin lymphoma, NHL, Launch, Europe

Cell Therapeutics initiates launch of Pixuvri in Europe

Article | 12 September 2012

Following the European approval of the drug this spring (The Pharma Letter May 14), US biotech firm Cell Therapeutics (Nasdaq and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in